Use of mifepristone and sublingual misoprostol for early medical abortion

Taiwanese Journal of Obstetrics and Gynecology

Volumn 45, Issue 4, 2006, Pages 321-324

  Lin, Mau ^a   Li, Yiu Tai ^a   Chen, Fu Min ^b   Wu, Shu Fang ^a   Tsai, Ching Wan ^a   Chen, Tien Hui ^a   Kuo, Tsung Cheng ^a  

^a KUO GENERAL HOSPITAL   (Taiwan)

^b Chung Shan Hospital   (Taiwan)

Author keywords

Medical abortion; Mifepristone; Sublingual misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; PARACETAMOL;

ABDOMINAL PAIN; ABORTION; ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CURETTAGE; DIARRHEA; DRUG EFFICACY; DRUG USE; FEMALE; FEVER; FOLLOW UP; GESTATION PERIOD; HEADACHE; HUMAN; INFECTION; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT SATISFACTION; PREGNANT WOMAN; SHIVERING; TRANSVAGINAL ECHOGRAPHY; VOMITING;

EID: 33846281525     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60251-5     Document Type: Article

References (13)

1. Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332-6.
2. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
3. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effect of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19:81-4.
4. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-13.
5. Kahn JG, Beaker BJ, MacIsaa L, et al. The efficacy of medical abortion: a meta-analysis. Contraception 2000;61:29-40.
6. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Eng J Med 1995;332:983-7.
7. Lin HW, Chien TY, Jeng CJ, Chen SC, Chen HF, Hwang JL. Comparison of two doses of mifepristone in combination with misoprostol for early pregnancy termination. Taiwanese J Obstet Gynecol 2002;41:155-61.
8. Kelly RW, Bukman A. Antiprogestagenic inhibition of uterine prostaglandin inactivation: a permissive mechanism for uterine stimulation. J Steroid Biochem Mol Biol 1990;37: 97-101.
9. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion, Contraception 1999;59:1-6.
10. Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001;64:315-7.
11. Cheung W, Tang OS, Lee SWH, Ho PC. Pilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks of gestation. Contraception 2003;68:47-9.
12. Tang OS, Chan CCW, Ng EHY, Lee SWH, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks' gestation. Hum Reprod 2003;18:2315-8.
13. Hamoda H, Ashok PW, Dow J, Flett GMM, Templeton FA. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days' gestation. Contraception 2003;68: 335-8.